In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and Richard Francis as new Division Head of Sandoz. 22 April 2014
Pharmaceutical
UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve Medlicott as Finance Director. 22 April 2014
Pharmaceutical
South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief Executive Officer, with immediate effect. 22 April 2014
Pharmaceutical
French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier, has died at the age of 92. 17 April 2014
Pharmaceutical
The US subsidiary of Japanese drug major Astellas Pharma announced that Jeffrey Bloss has been promoted to the position of senior vice president, medical affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Dr Bloss will serve as a member of the Astellas US management committee. 16 April 2014
Pharmaceutical
New Haven Pharmaceuticals, a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, to the newly-created position of Executive Vice President Operations. 2 April 2014
Pharmaceutical
USA-based Inovio Pharmaceuticals (NYSE MKT: INO) has announced the appointment of EJ Brandreth as Vice President of Quality. 1 April 2014
Pharmaceutical
Par Pharmaceutical Companies (NYSE: PRX) has announced the appointment of Terrance Coughlin as chief operating officer. 1 April 2014
Pharmaceutical
Novira Therapeutics has announced the appointment of Christian Schade as chief executive officer, effective March 19. 21 March 2014
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has announced the appointment of Giles Platford as Head of Commercial Operations, Emerging Markets. 19 March 2014
Pharmaceutical
UK-based company NeRRe Therapeutics, which is focused on the development of neurokinin (NK) receptor antagonists for a range of indications, has announced the appointment of Ian Nicholson as Chief Business Officer (CBO). 19 March 2014
Pharmaceutical
Avion Pharmaceuticals, a US-based specialty pharmaceutical company, has announced the promotion of Mike Sullivan to the position of president. 18 March 2014
Pharmaceutical
Germany-based Formycon has appointed Bernhard Hampl, a top pharmaceuticals manager from the USA, to its advisory board. 18 March 2014
Pharmaceutical
US headquartered Moderna Therapeutics, a leader in the development of RNA (mRNA) Therapeutics has announced that Lorence Kim will join Moderna's executive leadership team as chief financial officer, effective April 21. 7 March 2014
Pharmaceutical
Aquavit Pharmaceuticals, a private US-based life science company, has announced the appointment of David Goldberg as chief medical officer. 6 March 2014
Pharmaceutical
Belgium’s largest drugmaker, UCB, yesterday announced a succession plan for its chief excecutive, Roch Doliveux, saying that Jean-Christophe Tellier, currently executive vice president, Biopharma Brands and Solutions, will be appointed chief executive-elect and chairman of the executive committee as of March 1, 2014. 21 February 2014
Pharmaceutical
UK-based drug development company Avillion LLP has appointed Allison Jeynes-Ellis as chief executive. 18 February 2014
Pharmaceutical
US drug developer Inovio Pharmaceuticals has expanded its senior management team with two appointments to help advance the company's growing pipeline of preclinical and clinical DNA vaccines. 18 February 2014
Pharmaceutical
Ireland-headquartered drugmaker Shire (LSE: SHP) has announced that Graham Hetherington, chief financial officer, has decided to step down from the company. 13 February 2014
Pharmaceutical
European quotas for immigration could have an effect on the pharmaceutical industry, according to recruitment experts. 11 February 2014
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze